Recombinant human Enolase 1/ENO1 protein

Specific activity is > 20,000pmol/min/ug, and was obtained by measuring the decrease of NAD in absorbance at 340 nm resulting from NADH at pH 6.5 at 37C.

Alpha-enolase, 2-phospho-D-glycerate hydro-lyase, C-myc promoter-binding protein, Enolase 1, MBP-1, MPB-1, Non-neural enolase, NNE, Phosphopyruvate hydratase, PPH, Plasminogen-binding protein, ENO1L1, MBPB1, MPB1, ENO1-IT1, ENO1 intronic transcript 1

Specific activity is > 20,000pmol/min/ug, and was obtained by measuring the decrease of NAD in absorbance at 340 nm resulting from NADH at pH 6.5 at 37C.

Tau-crystallin, Tau crystallin, PPH, Plasminogen binding protein, Phosphopyruvate hydratase, Non-Neuronal Enolase (NNE), Non-Neuronal Enolase, Non Neuronal Enolase, NNE, MYC promoter-binding protein 1, MYC promoter binding protein 1, MPB-1, MPB1, MPB 1, MBPB-1, MBPB1, MBPB 1, MBP-1, MBP1, MBP 1, Enolase-1, Enolase1, Enolase 1 (alpha) like 1, Enolase 1 (alpha), Enolase 1, ENO1L1, ENO1, EC4.2.1.11, EC 4.2.1.11, C myc promoter binding protein, Alpha enolase, 2 phospho D glycerate hydro lyase, ATGP0404-10 µg, ATGP0404-20 µg, ATGP0404-50 µg, ATGP0404-100 µg, ATGP0404-250 µg, ATGP0404-500 µg, ATGP0404-1 mg, ATGP0404-010, ATGP0404-020, ATGP0404-050, ATGP0404-100, ATGP0404-250, ATGP0404-500, ATGP0404-01M

Chen X, et al. Interaction between granulin A and enolase 1 attenuates the migration and invasion of human hepatoma cells. (Oncotarget. 2017) {https://pubmed.ncbi.nlm.nih.gov/28415822/}; ; Hashimoto Y, et al. Comparison of clinical characteristics in patients with Vogt-Koyanagi-Harada disease with and without anti-retinal antibodies. (Graefes Arch Clin Exp Ophthalmol. 2019) {https://pubmed.ncbi.nlm.nih.gov/31065846/}; ; Hirakata T, et al. Acute unilateral inner retinal dysfunction with photophobia: importance of electrodiagnosis. (Jpn J Ophthalmol. 2020) {https://pubmed.ncbi.nlm.nih.gov/33180210/}; ; Hashimoto Y, et al. Comparison of clinical characteristics in patients with acute zonal occult outer retinopathy according to anti-retinal antibody status. (Graefes Arch Clin Exp Ophthalmol. 2021) {https://pubmed.ncbi.nlm.nih.gov/33876277/}; ; Inoue Y, et al. α-Enolase reduces cerebrovascular Aβ deposits by protecting Aβ amyloid formation. (Cell Mol Life Sci. 2022) {https://pubmed.ncbi.nlm.nih.gov/35916996/}

MSILKIHARE IFDSRGNPTV EVDLFTSKGL FRAAVPSGAS TGIYEALELR DNDKTRYMGK GVSKAVEHIN KTIAPALVSK KLNVTEQEKI DKLMIEMDGT ENKSKFGANA ILGVSLAVCK AGAVEKGVPL YRHIADLAGN SEVILPVPAF NVINGGSHAG NKLAMQEFMI LPVGAANFRE AMRIGAEVYH NLKNVIKEKY GKDATNVGDE GGFAPNILEN KEGLELLKTA IGKAGYTDKV VIGMDVAASE FFRSGKYDLD FKSPDDPSRY ISPDQLADLY KSFIKDYPVV SIEDPFDQDD WGAWQKFTAS AGIQVVGDDL TVTNPKRIAK AVNEKSCNCL LLKVNQIGSV TESLQACKLA QANGWGVMVS HRSGETEDTF IADLVVGLCT GQIKTGAPCR SERLAKYNQL LRIEEELGSK AKFAGRNFRN PLAK